145 related articles for article (PubMed ID: 1908245)
1. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells.
Chiodino C; Jones RF; Ethier SP
Mol Carcinog; 1991; 4(4):286-96. PubMed ID: 1908245
[TBL] [Abstract][Full Text] [Related]
2. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
3. Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats.
Ronai Z; Lau YY; Cohen LA
Mol Carcinog; 1991; 4(2):120-8. PubMed ID: 2043252
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
5. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
[TBL] [Abstract][Full Text] [Related]
6. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
Kumar R; Medina D; Sukumar S
Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
[TBL] [Abstract][Full Text] [Related]
7. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats.
Cha RS; Guerra L; Thilly WG; Zarbl H
Carcinogenesis; 1996 Nov; 17(11):2519-24. PubMed ID: 8968072
[TBL] [Abstract][Full Text] [Related]
8. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors.
Vuorio T; Wärri A; Sandberg M; Alitalo K; Vuorio E
Int J Cancer; 1988 Nov; 42(5):774-9. PubMed ID: 2972630
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations.
El-Sohemy A; Archer MC
Carcinogenesis; 2000 Apr; 21(4):827-31. PubMed ID: 10753223
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation and prevalence of ras gene mutations in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors.
Waldmann V; Suchy B; Rabes HM
Res Exp Med (Berl); 1993; 193(3):143-51. PubMed ID: 8356338
[TBL] [Abstract][Full Text] [Related]
12. Comparison of O6-methylguanine-DNA methyltransferase mRNA levels in Ha-ras mutated and non-mutated rat mammary tumors induced by N-methyl-N-nitrosourea.
Inui H; Watatani M; Yasutomi M; Nishisho I
Carcinogenesis; 1994 Mar; 15(3):459-63. PubMed ID: 8118929
[TBL] [Abstract][Full Text] [Related]
13. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice.
Qing WG; Conti CJ; LaBate M; Johnston D; Slaga TJ; MacLeod MC
Carcinogenesis; 1997 Mar; 18(3):553-9. PubMed ID: 9067556
[TBL] [Abstract][Full Text] [Related]
14. Absence of Ras mutations in rat DMBA-induced mammary tumors.
Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
[TBL] [Abstract][Full Text] [Related]
15. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
[TBL] [Abstract][Full Text] [Related]
17. ras oncogene activation in mammary carcinomas induced by N-methyl-N-nitrosourea in Copenhagen rats.
Lu SJ; Archer MC
Mol Carcinog; 1992; 6(4):260-5. PubMed ID: 1485917
[TBL] [Abstract][Full Text] [Related]
18. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels.
Zhang R; Haag JD; Gould MN
Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653
[TBL] [Abstract][Full Text] [Related]
19. Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands.
Sakai H; Ogawa K
Int J Cancer; 1991 Aug; 49(1):140-4. PubMed ID: 1874567
[TBL] [Abstract][Full Text] [Related]
20. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
Park CB; Fukamachi K; Takasuka N; Han BS; Kim CK; Hamaguchi T; Fujita K; Ueda S; Tsuda H
Cancer Sci; 2004 Mar; 95(3):205-10. PubMed ID: 15016318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
